All Articles tagged Engineered cellular therapy

• Correspondence
  September 27, 2024 BST
  Allogeneic and other innovative chimeric antigen receptor platforms
  Andrew P JalloukSalyka SengsayadethBipin N SavaniBhagirathbhai DholariaOlalekan Oluwole

  Chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment of hematologic malignancies. All of the CAR T-cell products that are currently FDA-approved are autologous.